✦ LIBER ✦

Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer

✍ Scribed by Andrea Ardizzoni; Editta Baldini; Carlo Mereu; Anna Verna; Gabriella L. Mariani; Riccardo Rosso; Marco Bonavia; Angela Cinquegrana; Fabio Ropolo; Carmelo Raso; Maurizio Viale; Silvano Ferrini; Sandra Molinari; Gerda J. Roest; Peter A. Palmer; John Sharenberg

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 756 KB
Volume: 73
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940301)73:5<1353::aid-cncr2820730508>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical effects and toxicity of interle

Clinical effects and toxicity of interleukin-2 in patients with cancer

✍ Michael T. Lotze; Yvedt L. Matory; Anthony A. Rayner; Stephen E. Ettinghausen; J 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 938 KB

Continuous-infusion cisplatin, 5-fluorou

Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer

✍ Thomas J. Lynch Jr.; John R. Clark; Leslie A. Kalish; Barbara G. Fallon; Anthony 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

Clinical patterns and treatment outcome

Clinical patterns and treatment outcome of elderly patients in clinical stage IB/II non-small cell lung cancer

✍ Tatsuro Okamoto; Riichiroh Maruyama; Fumihiro Shoji; Jiro Ikeda; Tetsuya Miyamot 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Abnormalities of protooncogenes in non-s

Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristics

✍ Martin J. Cline; Hector Battifora 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

Promising effects of adenosine triphosph

Promising effects of adenosine triphosphate infusion on nutritional status and quality of life in advanced non-small-cell lung cancer: a randomized clinical trial

✍ Pieter C. Dagnelie; Hendrik J. Agteresch 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Associations of ABCB1, ABCC2, and ABCG2

Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer

✍ Ji-Youn Han; Hyeong-Seok Lim; Yeon-Kyeong Yoo; Eun Soon Shin; Yong Hoon Park; Su 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

## Abstract ## BACKGROUND. The authors investigated whether __ABCB1, ABCC2,__ and __ABCG2__ genetic polymorphisms affect pharmacokinetics (PK) of irinotecan and treatment outcome of patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Blood samples from 107 NSCLC patients treate